Atea's AT-527, an Oral Antiviral Drug Candidate, Reduces Viral Replication in Hospitalized Patients with COVID-19 in Phase 2 Interim Analysis - BioSpace
Disease X Will Kill 80 Million In 36 Hours, WHO Panel Warns International Business Times A report by an independent monitoring body assembled by the World Health Organization (WHO) and The World Bank warned that a new pandemic could wipe ...
Comments
Post a Comment